ScreenerHero

ADOC Adocia SA

EPA · FR · Healthcare · Biotechnology · adocia.com
2.100EUR-1.41%Mkt Cap: 46.11M $P/E: —

Adocia SA, a clinical-stage biotechnology company, researches and develops therapeutic solutions for diabetes and obesity. Its proprietary BioChaperone technological platform provides molecular delivery of therapeutic pr…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.24BUSDP/E 29.3
REGN
Regeneron Pharmaceuticals, Inc.
$76.05BUSDP/E 18.3
MRNA
Moderna, Inc.
$74.84BUSD
ARGX
argenx SE
$56.77BUSDP/E 37.1
ARGX
argenx SE
$58.21BUSDP/E 35.5
UCB
UCB SA
$41.93BUSDP/E 17.9
RVMD
Revolution Medicines, Inc.
$42.84BUSD
ONC
BeOne Medicines AG
$41.27BUSDP/E 64.9
RPRX
Royalty Pharma plc
$32.61BUSDP/E 30.0
ALNY
Alnylam Pharmaceuticals, Inc.
$29.97BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.66BUSD
BNTX
BioNTech SE
$24.05BUSD
GMAB
Genmab A/S
$23.24BUSDP/E 29.8
INSM
Insmed Incorporated
$22.98BUSD
GMAB
Genmab A/S
$22.23BUSDP/E 30.6
INCY
Incyte Corporation
$22.85BUSDP/E 14.4
JAZZ
Jazz Pharmaceuticals plc
$15.02BUSDP/E 15.9
ASND
Ascendis Pharma A/S
$14.87BUSDP/E 17.3
EXEL
Exelixis, Inc.
$14.45BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$13.81BUSD

Key Statistics

Company
Market Cap46.11M USD
Enterprise Value—
Revenue (TTM)3.24M USD
Gross Profit742.39K USD
Net Income (TTM)-18.03M USD
Revenue/Share0.21 EUR
Last Price2.100 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees80
CountryFR
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.30
PEG—
EV/EBITDA—
EV/Revenue—
P/S14.54
P/B28.24
EPS (TTM)-0.79
EPS (Forward)-7.10
52W Range
2.0800% of range12.40
52W High12.40 EUR
52W Low2.080 EUR
Profitability
Gross Margin46.31%
Oper. Margin-596.17%
EBITDA Margin0.00%
Profit Margin-1124.81%
ROE-1112.74%
ROA-58.31%
Growth
Revenue Growth-39.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.10M USD
CapEx (TTM)290.22K USD
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity5.97
Current Ratio—
Quick Ratio—
Book Value/Sh0.08 EUR
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)9.700 EUR
Upside (mean)+361.9%
Target Range4.800 EUR – 12.00 EUR
4.800+361.9% to mean12.00
# Analysts4
Ownership
Shares Out.20.20M
Float16.27M
Insiders6.75%
Institutions7.85%
Technical
SMA 503.768 (-44.3%)
SMA 2004.883 (-57.0%)
Beta0.27
S&P 52W Chg14.58%
Avg Vol (30d)149.48K
Avg Vol (10d)302.11K
Technical Indicators
RSI (14)12.6
MACD-0.4676
MACD Signal-0.3450
MACD Hist.-0.1226
BB Upper4.449 EUR
BB Middle3.135 EUR
BB Lower1.820 EUR
BB Width83.86%
ATR (14)0.1899 EUR
Vol Ratio (20d)0.59x